A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients

Recruiting

Phase 1

Phase 2

Vemurafenib & MetforminA Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients

Sponsor:

University of Louisville

Code:

NCT01638676

Conditions

Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Vemurafenib

Metformin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by University of Louisville on 2021-10-29.